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Methionine adenosyl transferase (MAT) is an essential
enzyme that synthesizes AdoMet. The liver-specific MAT
isoform, MAT III, is a homodimer of a 43.7-kDa subunit
that organizes in three nonsequential - domains. Al-
though MAT III structure has been recently resolved,
little is known about its folding mechanism. Equilib-
rium unfolding and refolding of MAT III, and the mono-
meric mutant R265H, have been monitored using differ-
ent physical parameters. Tryptophanyl fluorescence
showed a three-state folding mechanism. The first un-
folding step was a folding/association process as indi-
cated by its dependence on protein concentration. The
monomeric folding intermediate produced was the pre-
dominant species between 1.5 and 3 M urea. It had a
relatively compact conformation with tryptophan resi-
dues and hydrophobic surfaces occluded from the sol-
vent, although its N-terminal region may be very un-
structured. The second unfolding step monitored the
denaturation of the intermediate. Refolding of the inter-
mediate showed first order kinetics, indicating the pres-
ence of a kinetic intermediate within the folding/associa-
tion transition. Its presence was confirmed by measuring
the 1,8-anilinonaphtalene-8-sulfonic acid binding in the
presence of tripolyphosphate. We propose that the fold-
ing rate-limiting step is the formation of an intermedi-
ate, probably a structured monomer with exposed hy-
drophobic surfaces, that rapidly associates to form
dimeric MAT III.
The classical investigation of Anfinsen and co-workers (1)
demonstrates that the sequence of amino acids that comprise a
polypeptide encodes the information required to reach the cor-
rect three-dimensional fold of a protein. However, the mecha-
nism by which the amino acid sequence directs the folding of a
protein is still unknown. Typically, protein folding studies have
concentrated on small, single domain proteins that fold rapidly
and avoid aggregation (2–4). However, in living cells, most
proteins have more than 100 residues with multiple folding
domains and subunits. These large proteins are not likely to
follow all of the folding principles established for smaller pro-
teins. They probably have more complex folding rules so that
models based on studies of small globular proteins may not
fully explain their folding and assembly (5). Folding of multido-
main or multisubunit proteins usually involves the formation
of partially folded intermediates. Although the basic principles
governing protein folding are probably general, folding of oli-
gomeric proteins may be a two-state process or involve mono-
meric or multimeric intermediates (6–9). Additionally, associ-
ation may occur from completely folded monomers (10–13), or
alternatively, final folding steps occur after association of par-
tially folded subunits (14). All these different mechanisms
make it difficult to derive a global mechanism to describe the
folding of oligomeric proteins, and consequently each protein
must be studied individually. Defining the complete folding
pathway requires the identification and characterization of all
stable and transient conformational states that exist along the
folding and unfolding pathways.
S-Adenosylmethionine (AdoMet)1 is an essential metabolite
in all cells. AdoMet is the most important biological methyl
group donor and is a precursor in the synthesis of polyamines
(15–17). Additionally, it has been recently demonstrated that
reduction of AdoMet levels in liver is associated with liver
injury and hepatocarcinoma (18). Methionine adenosyltrans-
ferase (MAT) (EC 2.5.1.6) catalyzes the only known AdoMet
biosynthetic reaction (19, 20). In all organisms studied so far,
from Escherichia coli to humans, sequence homologies show
that MAT is an exceptionally well conserved enzyme through
evolution (17). In mammalian tissues three different forms of
MAT (MAT I, MAT III, and MAT II) have been identified that
are the product of two different genes (MAT1A and MAT2A,
respectively) (21–25). The gene MAT2A encodes a 396-amino
acid catalytic subunit (2) expressed in all mammalian tissues
(16, 26). MAT II consist of 2 catalytic and  regulatory sub-
units, although the stoichiometry of the oligomer has not been
yet established. The gene MAT1A is expressed mainly in adult
liver and encodes a 395-amino acid catalytic subunit (1) that
organizes in dimers, MAT III, and tetramers, MAT I (17, 20).
The reason for the presence of these two different isoenzymes
in liver has not been yet elucidated, although it may be an
adaptation to the metabolic requirements of the liver. The liver
has the highest specific activity of MAT, which agrees with the
observation that up to 85% of all methylation reactions and as
much as 50% of methionine catabolism occur in this tissue (27,
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28). Based upon the different kinetic properties of MAT I and
MAT III isoforms, MAT III has been considered the liver-
specific enzyme. While MAT I, similar to MAT II in extrahe-
patic tissues, may maintain the basal AdoMet levels required
by cells, MAT III would be responsible for the clearance of
methionine after a load of this amino acid. E. coli and liver
MAT have been crystallized and their structure solved, show-
ing that the tetramer structure of both enzymes is essentially
the same (29–31). Each subunit consists of three structural
domains related to each other by a pseudo 3-fold symmetry.
Pairs of subunits form dimers, and each dimer is a tight com-
plex, with a wide interface area between subunits, that accom-
modate two active sites (29–31). The active site of the enzyme
is made by both subunits. However, no information about the
folding mechanism of MAT is still available. We have charac-
terized the folding-assembly pathway of MAT III, the specific
liver isoform, by identifying the intermediates involved in the
process. Our kinetic and equilibrium experiments indicate that
the folding of MAT III involves the formation of two folding
intermediates, which were identified by their intrinsic fluores-
cence, ANS binding capacity, and hydrodynamic volume.
EXPERIMENTAL PROCEDURES
Materials—Columns and chromatography media were from Amer-
sham Biosciences. Urea was from Invitrogen. All other reagents were
from Sigma.
Site-directed Mutagenesis—A 1.2-kilobase fragment containing the
rat MAT1A coding region (32) was subcloned into a pET vector. The
resulting plasmid includes a 5 sequence that encodes for 6 histidine
residues and a thrombin cleavage site in-frame with the rat liver
MAT1A coding region. Mutants were obtained by inverse polymerase
chain reaction according to the procedure of Pe´rez-Mato et al. (33).
Mutants were identified by sequencing the complete MAT cDNA.
Expression and Purification of His-tagged MAT I/III R265H Mu-
tant—MAT I/III R265H mutant was overexpressed in E. coli
BL21(DE3) as previously described (33). Recombinant MAT I/III R265H
mutant protein was purified from the bacterial cytosolic extracts by
affinity chromatography on a Ni2-Sepharose column equilibrated in 50
mM Tris/HCl, pH 8, 0.5 M NaCl, 75 mM imidazole following the proce-
dures described by Pe´rez-Mato et al. (33). No changes in the fluores-
cence, CD spectra, oligomeric state, and enzymatic activity were ob-
served after digestion of the recombinant proteins with thrombin (data
not shown). Therefore all the assays were carried out using the His-
tagged recombinant proteins.
Purification of MAT from Rat Liver—MAT III was purified from rat
liver according to the procedure described previously (34). Protein pu-
rity was more than 95% as estimated by SDS-PAGE (35).
Size Exclusion Chromatography—Protein samples (4.6 M) were an-
alyzed using a Superdex 200 HR 10/30 column equilibrated with 50 mM
Tris/HCl, pH 7.5, 150 mM KCl, 10 mM MgCl2 in an AKTA FPLC
(Amersham Biosciences). After sample injection (100 l), proteins were
isocratically eluted at a flow rate of 0.8 ml/min. Protein elution was
monitored by the absorbance at 280 nm. The elution volumes (ml) of the
standard proteins were: thyroglobulin (669 kDa), 8.1; ferritin (440 kDa),
10.22; catalase (232 kDa), 12.11; ovoalbumin (43 kDa), 14.73; chymo-
trypsin A (25 kDa), 18; ribonuclease A (13.7 kDa), 19. According to the
elution volume of the standard proteins, the estimated molecular
masses of native rat liver MAT III and R265H MAT I/III mutant were
90 and 41 kDa, respectively.
Equilibrium Denaturation Experiments—The buffer composition in
all equilibrium experiments was 50 mM Tris/HCl, pH 8, 4 mM MgCl2,
150 mM KCl, and 3.6 mM dithiothreitol with different urea concentra-
tions. All experiments were performed at 25 °C with the protein con-
centration indicated in the figure legends and incubated in the presence
of urea for at least 2 h. Unfolding was monitored by recording the
fluorescence emission spectra at each urea concentration from 300 to
450 nm emission wavelength using an excitation wavelength of 280 nm
in a PerkinElmer LS50B luminescence spectrometer. An emission
wavelength of 321 nm is used in all plots, because this is the wavelength
where differences were maximal. After recording the emission spectra,
ANS was added from a 1 mM stock solution to make a final concentra-
tion of 10 M. When required, tripolyphosphate/magnesium from a
stock of 50 mM was added to make a final concentration of 500 M. The
fluorescence at 470 nm emission wavelength was recorded in both cases
using an excitation wavelength of 350 nm. When unfolding was moni-
tored by measuring the tripolyphosphatase activity, MAT III was incu-
bated for 2 h at 25 °C in 990 l of the above buffer. After this time, the
reaction was started by addition of 10 l of tripolyphosphate/magne-
sium to make the final concentration 2 mM. At different incubation
times, aliquots of 100 l were removed to determine the formation of
inorganic phosphate according to the method of Lanzetta (36). For
refolding experiments MAT III was unfolded in the same buffer with a
final urea concentration of 8 M. After 2 h at 25 °C refolding was started
by diluting unfolded MAT III 20 times to obtain the desired urea
concentrations. Refolding proceeded for 2 additional hours. Fluores-
cence values were normalized by the protein concentration and ex-
pressed as arbitrary units per nanomolar MAT III monomers. Enzyme
activity was expressed as min1.
Refolding Kinetic Experiments—MAT III was partially unfolded for
2 h at 25 °C in the same buffer indicated above with a final urea
concentration ranging from 1.4 to 2.6 M. Refolding was started by a 1/10
dilution of the MAT III solution to obtain a final urea concentration of
0.26 M. Intrinsic fluorescence was monitored using excitation and emis-
sion wavelengths of 280 and 321 nm, respectively. When ANS binding
was monitored all solutions contained 10 M ANS, and refolding was
monitored using an excitation wavelength of 350 nm and an emission
wavelength of 470 nm. The approximate dead time was about 10 s.
Limited Proteolysis and Mass Spectrometry Analysis—Limited pro-
teolysis was performed by incubation of MAT III (0.5 mg/ml) with
trypsin (0.01 mg/ml) in 10 mM ammonium bicarbonate, pH 8, at 25 °C
for different periods of time. Protein fragments were analyzed by SDS-
PAGE. Mass spectrometry analysis was carried out with a Micromass
MALDI-TOF spectrometer. After digestion, reaction mixture was 5-fold
diluted with 0.1% trifluoroacetic acid and then spotted (1.5 l) onto the
MALDI target, where it was mixed with an equal volume of matrix
(cinnaminic acid). The analysis was performed using a laser energy of
70%, and Mr was calculated using adenocorticotropic hormone and
trypsin autolysis fragments as near point and internal standards,
respectively.
Data Analysis—Equilibrium experiments were all fitted to a three-
state model with a folding/association step and an additional folding
step (Equation 1). As discussed below, the folding intermediate is as-
sumed to be monomeric.
N2 ¢O¡
K1
2I ¢O¡
K2
2U (Eq. 1)
where N, I, and U are native, intermediate, and unfolded protein,
respectively. K1 and K2 are the equilibrium constants for the folding/
association and folding steps, respectively. If the species present at each
urea concentration are expressed as fraction (f), then the conservation
of mass and the equilibrium constants can be expressed as follows,
fN fI fU 1 (Eq. 2)
K1
2f I
2P
fN
; K2
fU
fI
(Eq. 3)
where P is the total concentration of MAT III subunits. From Equations
2 and 3, and solving for the fraction of each species we get the following
equation.
fI
K11K2
4P 1 1 8PK11K22;
fN 1 fI1K2; fU fIK2 (Eq. 4)
The dependence of the equilibrium constants on the denaturant (D)
concentration can be obtained form the free energy of unfolding Gu
GuRT ln Ku Gu
H2OmD (Eq. 5)
where Gu
H2O is the free energy of unfolding in water, and m is the
coefficient of dependence on the denaturant concentration.
The measured signals (SD) depend on the species composition at each
urea concentration according to the following equation,
SD SNfN SIfI SUfU (Eq. 6)
where SN, SI, and SU are the specific signal of native, intermediate, and
unfolded protein, respectively.
The equilibrium experiments were fitted in the spreadsheet Mi-
crosoft Excel as follows. The equilibrium constants K1 and K2 were
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calculated for each denaturant concentration using initial estimate
values of Gu
H2O and m. Then, the fraction of each species was calculated
using Equation 4. The specific signal of each species was then calcu-
lated as the regression coefficients of the fraction of the species in a
multiple linear regression analysis between the calculated fractions
and the measured signals at all urea concentrations, using a built-in
function of the program. This is like solving Equation 6 for all urea
concentrations. The theoretical signal was then calculated using Equa-
tion 6. The agreement between calculated and measured signal was
then evaluated by least square. Changing only Gu
H2O and m using an
iterative procedure (quasi-Newton method) obtained the best fit. In this
way, all the different types of signals measured could be fitted simul-
taneously to the same folding mechanism with only two variables per
transition. When several conditions were evaluate at the same time,
such as unfolding and refolding or different protein concentrations,
average specific signals were used to calculate the theoretical signal.
Sometimes the specific signal appeared to depend on the denaturant
concentration. In such cases, a slope was introduced in the fitting
process.
Kinetic data were fitted to single first or second order rate equations,
St S	 Aekt (Eq. 7)
St S	
A
1 Pkt
(Eq. 8)
where S(t) is the signal recorded at time t, S	 is the signal at t 
 	, A
is the amplitude of the signal, and k is the rate constant.
RESULTS
Intrinsic Fluorescence—The equilibrium unfolding and re-
folding in the presence of urea was monitored by changes in the
intrinsic fluorescence of MAT III at 321 nm (Fig. 1A). The
unfolding of MAT III was a completely reversible process with
two transitions. The initial drop in fluorescence was the result
of a decrease in intensity, whereas the second one reflected a
red shift of the spectrum without a significant change in fluo-
rescence intensity (inset in Fig. 1). These data indicate the
presence of a stable folding intermediate whose tryptophan
residues are still buried within the protein. The midpoints for
the transitions were 1.10 and 3.82 M urea using 0.28 M MAT
III monomer (see thermodynamic parameters in Table I).
Equilibrium experiments performed with the mutant
R265H, which is a monomer (37), also showed two transitions
(Fig. 1A). The first transition took place at a lower urea con-
centration compare with wild type MAT III, whereas the sec-
ond transition paralleled the one observed at 3.82 M urea. This
result suggests that both proteins unfold via the same folding
intermediate.
The second transition, corresponding to the unfolding of the
intermediate, must be a unimolecular process, since the R265H
mutant is a monomer. Thus, we studied the protein concentra-
tion dependence of the first transition. As shown in Fig. 1B, the
transition was shifted toward higher urea concentrations with
increasing MAT III concentrations. This result suggests that
the transition observed at about 1 M urea represents the fold-
ing/association process between native MAT III and a stable
intermediate.
Enzyme Activity and ANS Binding—Equilibrium experi-
ments were also monitored by measuring tripolyphosphatase
activity as well as ANS binding capacity. Both parameters
showed a single transition at about 1 M urea (Fig. 2A). ANS
binds to large patches of hydrophobic surface exposed to sol-
vent and has been widely used to probe folding intermediates.
However, ANS seemed to bind the native conformation of the
enzyme rather than the intermediate. We have determined an
apparent binding stoichiometry of 1 mol of ANS per MAT III
subunit (not shown), suggesting that ANS binds to a specific
site. Recently, the crystal structure of ANS bound to a single
site of a protein has been solved (38). A similar environment
FIG. 1. Intrinsic fluorescence. Unfolding and refolding of MAT III
was monitored by measuring the fluorescence at 321 nm at 25 °C as
described under “Experimental Procedures.” A, unfolding of MAT III
(E) and monomeric mutant R265H () was performed using a subunit
protein concentration of 280 nM. Refolding of MAT III (‚) was also
monitored. Inset, fluorescence spectra of MAT III at different urea
concentrations: 0 M (E), 2 M (), and 6 M (ƒ). B, unfolding of MAT III
was monitored at different subunit protein concentrations: 29 nM (Œ),
290 nM (E), and 1.48 M (f). The solid lines represent the fit to Equation
6 performed as described under “Experimental Procedures.” The fitting
parameters are indicated in Table I.
TABLE I
Fitting parameters
Thermodynamic parameters
Transition Protein m Gu
H2O D0.5
kcal mol1 M1 kcal mol1 M
1st R265H 1.31 0.09 0.07
1st wta 5.55 6.12 1.10
2nd Both 1.15 4.41 3.82
Global conformational stability
wt R265H
Gu (kcal mol
1) 14.93 4.32
Physicochemical parameters
Parameter Protein Fig. N I U
Intrinsic
fluorescence
wt 1A 0.84 0.60 0.32
R265H 1A 1.16
wt 1B 0.89 0.61 0.22
ANS
fluorescence
wt 2A 0.52 0.09 0.03
wt 2B 0.50 0.09 0.01
Activity wt 2A 3.60 0.17 0.13
Elution
volume
wt 3 14.25 14.38 13.07
R265H 3 15.31 14.36 13.10
Kinetic parameters
Urea [MAT] Amplitude k
M nM AU/nM min1
2.3 29.6 0.162 0.27
2.3 296 0.227 0.27
2.3 2960 0.178 0.24
1.4 296 0.169 0.23
2.0 296 0.184 0.20
2.3 296 0.168 0.21
2.6 296 0.183 0.22
a wt, wild type.
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was found in the MAT III structure at the entrance of sub-
strates to the active site. Supporting the existence of such a
binding site was the quenching of the fluorescence signal pro-
duced by the addition of the substrates of the enzyme (Fig. 2A).
Thus, enzyme activity and ANS binding are both probably
probing the conformation of the same structural domain of the
protein. This would explain the parallel loss of activity and
ANS binding upon unfolding of the native protein.
Hydrodynamic Volume—The compactness of the species
present at different urea concentrations was studied by gel
filtration chromatography. In the absence of urea the elution
volume of MAT III and R265H mutant corresponded to that of
dimeric (14.3 ml) and monomeric (15.3 ml) forms, respectively
(Fig. 3). However, as the urea concentration increased the
elution volume of both proteins became closer until reaching
the same intermediate value (14.4 ml) at about 1.25 M urea. At
higher urea concentrations the decrease in elution volume was
the same for MAT III and R265H mutant until reaching the
value of unfolded monomer (13.1 ml). These data also support
the presence of a common folding intermediate in the unfolding
pathway of both proteins. This folding intermediate had a less
compact structure than the monomer as indicated by its larger
hydrodynamic volume.
Trypsin Accessibility—To gain information about the confor-
mation of the folding intermediate, limited proteolysis experi-
ments were performed. In the absence of urea MAT III was
resistant to cleavage by trypsin for 1 h at 25 °C (Fig. 4). How-
ever, in the presence of 1 M urea, a single proteolytic fragment
was detected by SDS-PAGE. It was estimated to have about 3
kDa less than native MAT III. This is consistent with a single
cleavage either at the N- or C-terminal end of the protein. The
mass of the complementary fragment, as determined by mass
spectrometry, was 3480.5 Da, which is consistent with a cleav-
age at the N-terminal side of lysine 33. This residue is located
near the interacting interface between subunits. Thus, in order
for this residue to become accessible to trypsin, a monomeric
intermediate should be present.
Refolding Kinetics—To further characterize the transition
between native MAT III and its folding intermediate, the re-
folding kinetics was monitored by changes in fluorescence in-
tensity at 321 nm. To study the protein concentration depend-
ence, different concentrations of MAT III (from 0.3 to 30 M)
were incubated at 2.3 M urea. Under these conditions the fold-
ing intermediate represented over 95% of the protein. Refold-
ing was started upon a 1/10 dilution. The same refolding kinet-
ics was observed at all MAT III concentrations. Moreover, the
data could be fitted to a single exponential but was poorly
described by a second order rate equation, indicating that the
traces shown in Fig. 5 corresponded to monomolecular reac-
tions. Similar results were obtained when refolding was mon-
itored by ANS binding (not shown). These results imply that in
FIG. 2. ANS binding. Unfolding and refolding of MAT III was mon-
itored by its ANS binding capacity as well as by its tripolyphosphatase
activity as described under “Experimental Procedures.” A, ANS fluores-
cence during unfolding, in the absence (E) and in the presence of
tripolyphosphate (), and refolding, in the absence (‚) and in the
presence of tripolyphosphate (Œ), of MAT III using a subunit protein
concentration of 280 nM. The tripolyphosphatase activity during unfold-
ing () was also monitored using a subunit protein concentration of 296
nM. B, ANS fluorescence during unfolding of MAT III was monitored at
different subunit protein concentrations: 290 nM (E) and 1.48 M (f).
The solid lines represent the fit to Equation 6 performed as described
under “Experimental Procedures.” The fitting parameters are indicated
in Table I.
FIG. 3. Hydrodynamic volume. The compactness of the species
present at different urea concentrations was studied by gel filtration
chromatography using a subunit protein concentration of 4.6 M. The
elution volume of MAT III (E) and the R265H mutant () at different
urea concentrations is represented. The solid lines represent the fit to
Equation 6 performed as described under “Experimental Procedures.”
The fitting parameters are indicated in Table I.
FIG. 4. Trypsin accessibility of MAT III folding intermediate.
Limited proteolysis experiments were performed in the absence and in
the presence of 1 M urea as described under “Experimental Procedures.”
The protein subunit concentration was 11.4 M. Protein fragments were
analyzed by SDS-PAGE (top panel). The formation of the complemen-
tary fragment from MAT III trypsin digestion as well as its Mr was
determined by MALDI-TOF mass spectrometry analysis (bottom panel).
MAT III was incubated in the absence of urea for 60 min (trace a) or in
the presence of 1 M urea for 0 (trace b), 30 (trace c), and 60 (trace d) min.
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the folding pathway from the stable intermediate to the native
protein there must be at least one kinetic folding intermediate.
In an attempt to obtain some physical evidence of the existence
of this intermediate, we measured the binding of ANS in the
presence of tripolyphosphate using a MAT III concentration of
1.48 M. Fig. 6 shows a transient binding of ANS within the
transition observed at about 1 M urea, indicating the presence
of the intermediate. However, when refolding started from urea
concentrations ranging from 1.4 to 2.6 M, the same kinetics,
with no significant loss of amplitude, were observed (Table I).
These results suggest that it is a folding intermediate that is
not significantly populated in our equilibrium experiments.
However, it must bind a large amount of ANS nonspecifically in
order to be detected.
DISCUSSION
The overall unfolding pathway for a dimeric protein must
begin with the folded dimer (N2) and end with two unfolded
monomers (2U). The way in which this process occurs depends
on whether intermediates are present along the pathway. Nu-
merous examples exist of compact monomeric or dimeric inter-
mediates that are significantly populated during the equilib-
rium denaturation of a folded dimer (6–9). However, far from
being a general mechanism, the formation and role of these
intermediates needs to be addressed in light of the protein
under investigation. Here we describe the folding mechanism
of MAT III, the liver isoform of a ubiquitous enzyme that
synthesizes AdoMet. MAT III is a homodimer of a 43.7-kDa
subunit (17, 20) that organizes in three nonsequential -
domains (29–31). Although the MAT III structure has been
recently resolved, little is known about its folding mechanism.
All our results from equilibrium experiments have been fit-
ted to the following folding scheme,
2U ¢O¡
folding
2I ¢O¡
folding/association
N2
SCHEME 1
where U, I, and N denote unfolded, intermediate, and native
protein, respectively.
Unfolding of MAT III is a reversible process with formation
of a stable monomeric folding intermediate. A fully reversible
three-state folding process was observed when unfolding was
monitored by fluorescence, indicating the presence of a stable
folding intermediate. Gel filtration experiments also supported
these results. On the contrary, only a single transition, corre-
sponding to the formation of the intermediate, was observed by
measuring tripolyphosphatase activity or ANS binding. The
folding intermediate was the predominant species between 1.5
and 3 M urea. Unfolding of the mutant R265H also showed a
three-state folding mechanism. The second transition of both
proteins, corresponding to the unfolding of the intermediate,
was identical, which strongly suggests that they both unfold
via the same folding intermediate. Since R265H is a monomeric
mutant (37) (and it is involved only in monomolecular reac-
tions, not shown), the folding intermediate must also be a
monomer. The first transition observed in the case of the mu-
tant protein, however, took place at a lower urea concentration,
indicating that the monomeric mutant is less stable than di-
meric MAT III at the same protein concentration. Moreover,
even in the absence of urea, the R265H mutant seemed to be in
equilibrium with the folding intermediate, because no plateau
was observed.
The stable folding intermediate may be a molten globule. The
physicochemical properties of the folding intermediate are sim-
ilar to those proposed for the molten globule (39). It has an
intermediate compactness as indicated by its hydrodynamic
volume, which is larger than the monomer, but much smaller
than the unfolded protein. Its fluorescence spectrum indicated
that tryptophan fluorescence was quenched (compare with na-
tive protein). However, tryptophan residues did not seem to be
exposed to the solvent, because the emission maximum was the
same as in the native protein. After its unfolding, a red shift of
the spectrum was observed, indicating their exposure to the
media. The folding intermediate was inactive and unable to
bind ANS specifically (see below). There were no hydrophobic
patches exposed to the solvent, because it did not bind ANS,
indicating that the dimerization interface was not accessible.
Lysine 33 is located more or less in the middle of the dimeriza-
tion interface with its side chain buried within the protein.
Thus, to be accessible to trypsin digestion the folding interme-
diate must be a monomer with the dimerization interface com-
pletely altered. This lysine residue appeared to be the most
sensitive toward trypsin cleavage, even more than lysine resi-
dues at the surface of the protein, which suggests that the
N-terminal region might be extended.
There is a specific binding site for ANS that may be located
near the access to the active site. The apparent binding stoi-
chiometry of 1 mol of ANS per MAT III subunit suggests that
ANS binds to a specific binding site. Recently, the crystal
structure of a binding site for ANS has been described (38).
ANS is stacked in a hydrophobic cleft made by the sequence
Pro-Gly at one side and the hydrophobic side chain of an argi-
nine at the other side. A similar environment is also found in
MAT III. The only Pro-Gly sequence in MAT III is located
opposed to the hydrophobic side chains of Val-Gly-Ala. This last
FIG. 5. Refolding kinetics. Refolding of MAT III was monitored by
recording the fluorescence at 321 nm. A, different subunit protein
concentrations were used: 29.6 nM (, dashed line), 296 nM (E, thick
line), and 2.96 M (ƒ, thin line). The data were fitted to a first or second
order rate equation as described under “Experimental Procedures.” The
fitting parameters are indicated in Table I. Normalized traces are
shown. B, residuals of the fit of the 296 nM trace to a first (continuous
line) or second order (dashed line) rate equation.
FIG. 6. Kinetic folding intermediate. MAT III was incubated at
different urea concentrations in the presence of 10 M ANS and 500 M
tripolyphosphate as described under “Experimental Procedures.” The
protein subunit concentration was 1.48 M.
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sequence is at the beginning of the loop that limits the access to
the active site of the enzyme and that is probably involved in
catalysis (40). The quenching of ANS fluorescence after addi-
tion of substrates supports the location of this putative binding
site. Moreover, the loss of activity paralleled the quenching of
ANS fluorescence, suggesting that they are probing the same
structural domain of the protein.
There is a kinetic intermediate between native protein and
the stable folding intermediate. The first transition, at about 1
M urea, was dependent on protein concentration. This implies a
folding/association reaction, because the folding intermediate
is a monomer. However, refolding kinetics only showed a first
order process, which can only be explained by the presence of a
kinetic intermediate. This kinetic intermediate could be mono-
meric or dimeric. If a dimeric intermediate was present, all of
the following conditions should be met: 1) the spectroscopic
properties of the dimeric intermediate should be identical to
that of the monomeric folding intermediate so that there is no
loss of amplitude; 2) formation of the intermediate should be
much faster than subsequent monomolecular steps. It should
be completed within the dead time (about 10 s) of our experi-
ments, otherwise a protein concentration-dependent lag phase
should be present; 3) the kinetic intermediate should accumu-
late within the dead time. However, our data do not support all
these requirements. Whereas the first requirement might be
true for intrinsic fluorescence, it did not seem to hold for fluo-
rescence due to ANS binding (Fig. 6). Then, accumulation of the
kinetic intermediate would produce different kinetics (with
losses of amplitude) when monitored by tryptophan or ANS
fluorescence. Thus, the kinetic intermediate is most probably a
monomer. There are several possibilities regarding the spec-
troscopic properties and the rate-limiting step. However, the
simplest mechanism that explains our data with the minimum
number of assumptions is a monomeric intermediate with spec-
troscopic properties (at least intrinsic fluorescence) like those
of the native protein and whose formation (the folding step) is
rate-limiting. Thus, no protein-dependent lag phases nor losses
of amplitude, which were not seen, should be expected. It could
be speculated that this kinetic intermediate would be the
folded or very structured monomer. Thus, exposure of the large
hydrophobic dimer interface would be energetically unfavor-
able so that association is expected to be very fast, maybe
diffusion-controlled. This would also explain the high nonspe-
cific binding of ANS of the intermediate.
We propose that both MAT III and the R265H mutant would
share the two folding intermediates described here. However,
once the kinetic folding intermediate would be formed the
folding pathways of both proteins would diverge. In the case of
MAT III, association of two monomers would take place rap-
idly. Since association is impaired in the case of the R265H
mutant, an alternative, more compact monomeric conformation
would be produced. This conformation would presumably oc-
clude the mainly hydrophobic interface between subunits to
stabilize a monomeric conformation.
In summary, our results indicate that MAT III unfolding is
fully reversible with the following proposed folding mechanism,
U ¢O¡
folding
2I ¢O¡
folding(slow)
2Ik ¢O¡
association(fast)
N2
8
N*m
SCHEME 2
where U, I, and N denote unfolded, intermediate, and native
protein, respectively, and the subscript k indicates that it is a
kinetic intermediate. The subscript m and the asterisk indicate
that it is a monomeric mutant with an altered native-like
conformation. The stable monomeric folding intermediate has
an altered non-native dimerization interface with no exposure
of hydrophobic patches or tryptophan residues to the solvent.
Although it is less compact than native MAT III, it is much
more compact than unfolded protein. The kinetic intermediate
present in the transition between the stable folding intermedi-
ate and native MAT III is most probably a monomer whose
formation is rate-limiting and associates very rapidly to form
native MAT III. The monomeric mutant R265H unfolds via the
same stable folding and, probably, kinetic intermediates. Our
data also indicate that ANS binds MAT III specifically at a site
that is probably located near the access to the active site.
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